Full history for every metric is available with a Kvantra account
KMS Medisurgi Limited (KMSMEDI.BO)
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | INR m | 75 | 103 | 110 | 139 | 139 | 122 | 122 |
| Operating profit | INR m | 4 | 4 | |||||
| Net profit | INR m | 1 | 2 | 6 | 5 | 4 | 2 | 2 |
| EPS reported | INR | 0.74 | 0.74 | |||||
| Operating cashflow per share | INR | 4.26 | 4.04 | |||||
| Capex per share | INR | 5.18 | 4.91 | |||||
| FCF per share | INR | -0.92 | -0.88 | |||||
| Free cash flow | INR m | -3 | -3 | |||||
| Net debt | INR m | -3 | -3 | |||||
| Book value equity | INR m | 83 | 83 | |||||
| Book value per share | INR | 25.06 | 23.76 | |||||
| Number of shares | m | 3.32 | 3.5 | |||||
| DPS (TTM paid) | INR | 0.05 | 0.05 |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 170.95 | - | |||||
| P/B LTM | x | 5.05 | 5.27 | |||||
| P/S LTM | x | 3.44 | 3.59 | |||||
| P/FCF LTM | x | -136.85 | -142.89 | |||||
| EV/EBITDA LTM | x | 46.39 | 46.15 | |||||
| EV/Sales LTM | x | 3.41 | 3.56 | |||||
| Earnings Yield LTM | % | 0.58% | 0.53% | |||||
| FCF Yield | % | -0.73% | -0.70% | |||||
| Quality | ||||||||
| ROE | % | 2.95% | 2.95% | |||||
| ROIC | % | 3.49% | 3.49% | |||||
| Operating margin | % | 3.49% | 3.49% | |||||
| Gross margin | % | 13.19% | 13.19% | |||||
| FCF/Sales | % | -2.51% | -2.51% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -44.36% | -44.36% | |||||
| Sales Growth YoY | % | -12.41% | -12.41% | |||||
| Net Income Growth YoY | % | -44.18% | -44.18% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | -35.83% | -35.83% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.04% | 0.04% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 6.72% | 6.72% | |||||
| FCF/Debt | x | -0.40 | -0.40 | |||||
| Net Debt/EBITDA | x | -0.37 | -0.35 | |||||
| EBIT/Net interest | x | 4.01 | 4.01 | |||||
| Net debt/market cap | % | -0.79% | -0.76% | |||||
| Net debt/Equity | x | -0.04 | -0.04 | |||||
| Gross debt/equity | x | 0.09 | 0.09 | |||||
Company overview
KMS Medisurgi Limited primarily manufactures medical and surgical apparatus. The company also specializes in the commercialization and distribution of a diverse range of healthcare products, including various medical instruments, single-use surgical items, hemostats, surgical systems, and specialized equipment for fields such as radiology, oncology, diagnostics, cardiology, critical care, urology, and scientific research. This enterprise was established by Gaurang Prataprai Kanakia on March 25, 1999, and maintains its corporate headquarters in Mumbai, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
KMS Medisurgi Limited (KMSMEDI.BO)
KMS Medisurgi Limited primarily manufactures medical and surgical apparatus. The company also specializes in the commercialization and distribution of a diverse range of healthcare products, including various medical instruments, single-use surgical items, hemostats, surgical systems, and specialized equipment for fields such as radiology, oncology, diagnostics, cardiology, critical care, urology, and scientific research. This enterprise was established by Gaurang Prataprai Kanakia on March 25, 1999, and maintains its corporate headquarters in Mumbai, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free